Wesana Health Holdings Inc.
WSNAF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | 0.07 | 0.01 | 0.00 |
| FCF Yield | -5.32% | -36.59% | -19.00% | -24.04% |
| EV / EBITDA | -15.71 | -3.37 | -4.05 | -4.23 |
| Quality | ||||
| ROIC | 9.25% | 49.42% | 53.51% | 738.91% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 3.58 | 0.88 | 0.73 | 0.60 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -100.00% |
| Free Cash Flow Growth | 90.29% | -11.75% | -90.51% | 67.27% |
| Safety | ||||
| Net Debt / EBITDA | -6.22 | -0.96 | -0.22 | -1.61 |
| Interest Coverage | -9.05 | -121.14 | -124.18 | -28.72 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |